Glaukos Corp. (GKOS)
236.80
-1.94
(-0.81%)
USD |
NYSE |
Nov 10, 16:00
240.76
+3.96
(+1.67%)
After-Hours: 19:09
Glaukos Cash from Operations (Annual) : -14.79M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -14.79M |
| December 31, 2024 | -61.32M |
| December 31, 2023 | -57.76M |
| December 31, 2022 | -33.08M |
| December 31, 2021 | 24.71M |
| December 31, 2020 | -22.99M |
| December 31, 2019 | -0.369M |
| Date | Value |
|---|---|
| December 31, 2018 | 18.86M |
| December 31, 2017 | 25.43M |
| December 31, 2016 | 12.31M |
| December 31, 2015 | -2.188M |
| December 31, 2014 | -7.107M |
| December 31, 2013 | -13.30M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Globus Medical, Inc. | 753.45M |
| Intuitive Surgical, Inc. | 3.030B |
| Becton, Dickinson & Co. | 3.365B |
| Merit Medical Systems, Inc. | 297.37M |
| Edwards Lifesciences Corp. | 1.595B |